You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/15/12 | 8-K | Current report filing |
|
10 | |
| 08/14/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 08/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
   |
44 |
| 08/13/12 | EFFECT | Notice of Effectiveness |
|
1 | |
| 08/13/12 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
|
12 |
| 08/10/12 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
203 | |
| 08/09/12 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 07/25/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/23/12 | 8-K | Current report filing |
|
4 | |
| 07/19/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 |
